TipRanks
Bioqual Inc (BIOQ)
OTHER OTC:BIOQ
US Market
BIOQ
Bioqual
RESEARCH TOOLSreports
Want to see BIOQ full AI Analyst Report?

Bioqual (BIOQ) Ratios

19 Followers

Bioqual Ratios

BIOQ's free cash flow for Q1 2025 was $0.09. For the 2025 fiscal year, BIOQ's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Aug 25Aug 24Aug 23May 23
Liquidity Ratios
Current Ratio
 ― 4.22 3.72 4.02 3.61
Quick Ratio
 ― 4.22 3.72 4.02 3.61
Cash Ratio
 ― 1.75 2.12 2.03 0.88
Solvency Ratio
 ― -0.05 0.06 0.16 0.28
Operating Cash Flow Ratio
 ― 0.06 0.35 1.22 0.99
Short-Term Operating Cash Flow Coverage
 ― 0.11 0.74 2.61 2.39
Net Current Asset Value
$ ―$ -9.20M$ 10.34M$ 11.94M$ 6.24M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.48 0.29 0.06 0.30
Debt-to-Equity Ratio
 ― 1.01 0.46 0.10 0.49
Debt-to-Capital Ratio
 ― 0.50 0.31 0.09 0.33
Long-Term Debt-to-Capital Ratio
 ― 0.00 0.00 0.00 0.29
Financial Leverage Ratio
 ― 2.11 1.58 1.50 1.63
Debt Service Coverage Ratio
 ― -0.84 0.19 0.85 1.94
Interest Coverage Ratio
 ― 0.00 0.00 0.00 0.00
Debt to Market Cap
 ― 0.11 0.10 0.06 0.27
Interest Debt Per Share
 ― 36.57 18.49 4.01 20.71
Net Debt to EBITDA
 ― -9.58 -2.58 -3.96 1.63
Profitability Margins
Gross Profit Margin
―3.59%-3.88%12.68%20.11%
EBIT Margin
―-11.19%-3.88%0.81%1.81%
EBITDA Margin
―-5.64%1.04%5.18%11.12%
Operating Profit Margin
―-11.19%-3.88%-0.03%1.76%
Pretax Profit Margin
―-9.30%-2.63%0.81%1.81%
Net Profit Margin
―-10.44%-2.14%0.83%1.33%
Continuous Operations Profit Margin
―-10.44%-2.14%0.83%1.33%
Net Income Per EBT
―112.18%81.47%101.48%73.73%
EBT Per EBIT
―83.11%67.86%-2426.15%102.75%
Return on Assets (ROA)
―-6.09%-1.84%0.85%1.36%
Return on Equity (ROE)
―-12.86%-2.90%1.28%2.22%
Return on Capital Employed (ROCE)
―-7.20%-3.89%-0.04%2.08%
Return on Invested Capital (ROIC)
―-6.85%-2.93%-0.04%1.44%
Return on Tangible Assets
―-6.18%-1.87%0.87%1.39%
Earnings Yield
―-14.34%-2.60%0.74%1.22%
Efficiency Ratios
Receivables Turnover
 ― 3.82 3.71 4.18 2.94
Payables Turnover
 ― 36.86 26.75 37.09 31.40
Inventory Turnover
 ― 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 ― 1.04 2.01 2.38 2.06
Asset Turnover
 ― 0.58 0.86 1.04 1.02
Working Capital Turnover Ratio
 ― 1.84 2.12 2.61 2.87
Cash Conversion Cycle
 ― 85.60 84.69 77.39 112.55
Days of Sales Outstanding
 ― 95.50 98.33 87.24 124.17
Days of Inventory Outstanding
 ― 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 ― 9.90 13.64 9.84 11.62
Operating Cycle
 ― 95.50 98.33 87.24 124.17
Cash Flow Ratios
Operating Cash Flow Per Share
 ― 0.39 3.29 10.45 9.16
Free Cash Flow Per Share
 ― -0.07 3.03 9.79 6.66
CapEx Per Share
 ― 0.47 0.27 0.67 2.50
Free Cash Flow to Operating Cash Flow
 ― -0.19 0.92 0.94 0.73
Dividend Paid and CapEx Coverage Ratio
 ― 0.84 4.29 8.96 2.62
Capital Expenditure Coverage Ratio
 ― 0.84 12.33 15.67 3.67
Operating Cash Flow Coverage Ratio
 ― 0.01 0.18 2.61 0.44
Operating Cash Flow to Sales Ratio
 ― <0.01 0.06 0.16 0.13
Free Cash Flow Yield
―-0.23%6.72%13.50%8.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -6.97 -38.46 134.26 81.72
Price-to-Sales (P/S) Ratio
 ― 0.73 0.82 1.11 1.09
Price-to-Book (P/B) Ratio
 ― 0.90 1.11 1.72 1.82
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -435.29 14.87 7.41 11.40
Price-to-Operating Cash Flow Ratio
 ― 82.71 13.67 6.94 8.30
Price-to-Earnings Growth (PEG) Ratio
 ― -0.02 0.12 -3.20 -0.97
Price-to-Fair Value
 ― 0.90 1.11 1.72 1.82
Enterprise Value Multiple
 ― -22.47 76.40 17.45 11.43
Enterprise Value
 ― 50.66M 38.94M 52.90M 79.61M
EV to EBITDA
 ― -22.47 76.40 17.45 11.43
EV to Sales
 ― 1.27 0.80 0.90 1.27
EV to Free Cash Flow
 ― -758.55 14.39 6.04 13.30
EV to Operating Cash Flow
 ― 144.14 13.22 5.65 9.67
Tangible Book Value Per Share
 ― 35.08 39.27 40.90 40.72
Shareholders’ Equity Per Share
 ― 36.23 40.42 42.05 41.87
Tax and Other Ratios
Effective Tax Rate
 ― -0.12 0.19 -0.01 0.26
Revenue Per Share
 ― 44.66 54.64 65.44 69.75
Net Income Per Share
 ― -4.66 -1.17 0.54 0.93
Tax Burden
 ― 1.12 0.81 1.01 0.74
Interest Burden
 ― 0.83 0.68 1.00 1.00
Research & Development to Revenue
 ― 0.01 0.00 0.00 0.01
SG&A to Revenue
 ― 0.13 0.13 0.00 0.12
Stock-Based Compensation to Revenue
 ― 0.00 0.00 0.00 0.00
Income Quality
 ― -0.08 -2.81 19.36 9.85
Currency in USD